Akebia Files Lawsuit Against CMS for 2018 Action Rescinding Medicare Part D Coverage of FDA-Approved Auryxia for its Iron Deficiency Anemia Indication and Imposing...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 15, 2019--
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 15, 2019--